These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17270020)

  • 1. Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis.
    Koshida S; Kobayashi D; Moriai R; Tsuji N; Watanabe N
    Cancer Sci; 2007 Mar; 98(3):315-20. PubMed ID: 17270020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells.
    Kobayashi D; Koshida S; Moriai R; Tsuji N; Watanabe N
    Cancer Sci; 2007 Mar; 98(3):334-40. PubMed ID: 17270022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
    Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
    Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin mRNA expression in patients with breast cancer.
    Nasu S; Yagihashi A; Izawa A; Saito K; Asanuma K; Nakamura M; Kobayashi D; Okazaki M; Watanabe N
    Anticancer Res; 2002; 22(3):1839-43. PubMed ID: 12168879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactomedin-4 in digestive diseases: A mini-review.
    Wang XY; Chen SH; Zhang YN; Xu CF
    World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of peptide deformylase in breast, colon, and lung cancers.
    Randhawa H; Chikara S; Gehring D; Yildirim T; Menon J; Reindl KM
    BMC Cancer; 2013 Jul; 13():321. PubMed ID: 23815882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic Approach.
    Valo I; Raro P; Boissard A; Maarouf A; Jézéquel P; Verriele V; Campone M; Coqueret O; Guette C
    Proteomics; 2019 Nov; 19(21-22):e1800446. PubMed ID: 31318138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the antiapoptotic protein survivin in colon cancer.
    Hernandez JM; Farma JM; Coppola D; Hakam A; Fulp WJ; Chen DT; Siegel EM; Yeatman TJ; Shibata D
    Clin Colorectal Cancer; 2011 Sep; 10(3):188-93. PubMed ID: 21855041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.
    Liu W; Liu Y; Zhu J; Wright E; Ding I; Rodgers GP
    Clin Cancer Res; 2008 Feb; 14(4):1041-9. PubMed ID: 18281536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.
    Su W; Luo L; Wu F; Lai Z; Li X; Xie Z; Tang Z; Yang Z; Liang R
    Hum Pathol; 2015 May; 46(5):732-8. PubMed ID: 25771901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of c-erbB2, PLU-1 and survivin mRNA expression to diagnostic assessment of breast cancer.
    Izawa A; Kobayashi D; Nasu S; Saito K; Moriai R; Asanuma K; Nakamura M; Yagihashi A; Watanabe N
    Anticancer Res; 2002; 22(5):2965-9. PubMed ID: 12530026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
    Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
    Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.
    Tsuji N; Furuse K; Asanuma K; Furuya M; Kondoh K; Kamagata C; Sasaki M; Kobayashi D; Yagihashi A; Takahashi H; Watanabe N
    Breast Cancer Res Treat; 2004 Sep; 87(1):23-31. PubMed ID: 15377848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells.
    Liu RH; Yang MH; Xiang H; Bao LM; Yang HA; Yue LW; Jiang X; Ang N; Wu LY; Huang Y
    J Biomed Sci; 2012 Apr; 19(1):38. PubMed ID: 22471589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma.
    Ye L; Kriegl L; Reiter FP; Munker SM; Itzel T; Teufel A; Ziesch A; Török HP; Kirchner T; Gerbes AL; Guba M; Mayerle J; De Toni EN
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00124. PubMed ID: 31990698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor.
    Chin KL; Aerbajinai W; Zhu J; Drew L; Chen L; Liu W; Rodgers GP
    Br J Haematol; 2008 Nov; 143(3):421-32. PubMed ID: 18764868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of IAP family proteins in colon cancers from patients with different age groups.
    Endo T; Abe S; Seidlar HB; Nagaoka S; Takemura T; Utsuyama M; Kitagawa M; Hirokawa K
    Cancer Immunol Immunother; 2004 Sep; 53(9):770-6. PubMed ID: 15138717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.
    Oue N; Sentani K; Noguchi T; Ohara S; Sakamoto N; Hayashi T; Anami K; Motoshita J; Ito M; Tanaka S; Yoshida K; Yasui W
    Int J Cancer; 2009 Nov; 125(10):2383-92. PubMed ID: 19670418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas.
    Díaz R; González-Sancho JM; Soldevilla B; Silva J; García JM; García V; Peña C; Herrera M; Gómez I; Bonilla F; Domínguez G
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1135-42. PubMed ID: 20842728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer.
    Li J; Chen P; Li XQ; Bao QL; Dai CH; Ge LP
    Int J Cancer; 2013 Mar; 132(5):1098-104. PubMed ID: 22930255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.